IDH1 and astrocytoma (excluding glioblastoma): RNA-sequencing of primary IDH-mutant astrocytomas included in the CATNON trial was successfully performed for 138 samples and extended with transcriptomic data from the TCGA (n = 247), GLASS-NL-P (n = 65) and GLASS-NL-R (n = 102) datasets.